Purinergic (P2X) Receptor Antagonists
| Cat. No. | Product Name / Activity |
|---|---|
| 6493 | A 317491 sodium salt |
| Selective, high affinity P2X3 and P2X2/3 antagonist; antinociceptive | |
| 2972 | A 438079 hydrochloride |
| Competitive P2X7 antagonist | |
| 3701 | A 740003 |
| Potent and selective P2X7 antagonist | |
| 4473 | A 804598 |
| Potent and selective P2X7 antagonist | |
| 3323 | AZ 10606120 dihydrochloride |
| Potent P2X7 antagonist | |
| 3317 | AZ 11645373 |
| Potent and selective human P2X7 antagonist | |
| 7573 | BAY 1797 |
| Selective P2X4 antagonist | |
| 3579 | 5-BDBD |
| Potent and selective P2X4 antagonist | |
| 5545 | BX 430 |
| Selective P2X4 allosteric antagonist | |
| 0845 | Evans Blue tetrasodium salt |
| P2X antagonist; also non-NMDA iGluR antagonist; inhibits L-glutamate uptake into synaptic vesicles | |
| 2611 | IMD 0354 |
| P2X1, P2X4 and P2X7 antagonist; also inhibitor of IKKβ | |
| 5299 | JNJ 47965567 |
| Potent and selective P2X7 antagonist; brain penetrant | |
| 1277 | KN-62 |
| Non-competitive P2X7 antagonist | |
| 1240 | NF 023 |
| Selective and competitive P2X1 antagonist | |
| 2548 | NF 110 |
| Potent P2X3 antagonist | |
| 2450 | NF 157 |
| Selective P2Y11 and P2X1 antagonist | |
| 1199 | NF 279 |
| Potent and selective P2X1 antagonist | |
| 1391 | NF 449 |
| Highly selective P2X1 antagonist | |
| 0625 | PPADS tetrasodium salt |
| Non-selective P2 antagonist | |
| 0683 | iso-PPADS tetrasodium salt |
| Non-selective P2X antagonist | |
| 4391 | Ro 51 |
| Potent P2X3 and P2X2/3 antagonist | |
| 3052 | RO-3 |
| Selective P2X3 and P2X2/3 antagonist | |
| 1472 | Suramin hexasodium salt |
| Non-selective P2 antagonist | |
| 2464 | TNP-ATP triethylammonium salt |
| Potent and selective P2X antagonist |
P2 Receptors Scientific Review
Our Purine Receptor review gives an overview of the subtypes and structures of the P2 receptor family, and the pharmacological ligands used to study them.
Request copyRequest PDF